Why a Budding Drug-Price Revolution Isn’t Quite What It Seems
Companies like Cigna and CVS are promising simpler prices, but the behind-the-scenes system remains complex.
| Ticker |
CVS
|
| CIK | 0000064803 |
| SIC | 5912 |
| Sector | Retail Trade |
| Industry Category | Retail |
| Industry Group | Retail – Drug & Proprietary Stores |
| Address | ONE CVS DR., WOONSOCKET, RI, 02895 |
| Website | cvshealth.com |
| Phone | 4017651500 |
| CEO | Karen S. Lynch |
| Employees | 300,000 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Why a Budding Drug-Price Revolution Isn’t Quite What It SeemsCompanies like Cigna and CVS are promising simpler prices, but the behind-the-scenes system remains complex. CVS Health (CVS): Reassessing Valuation After Raised 2025–2026 Guidance and New AI Consumer PlatformCVS Health (CVS) just put fresh numbers on the table, raising its outlook for 2025 and sketching out higher earnings in 2026, and investors are paying attention because this guidance is tied to tangible progress in Aetna, pharmacy benefits and a new AI driven consumer platform. See our latest analysis for CVS Health. The guidance upgrade has been matched by price action, with CVS delivering a roughly 79 percent year to date share price return and a 59 percent one year total shareholder... CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreakAs South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS Health® (NYSE:CVS) is offering the measles-mumps-rubella (MMR) vaccine to residents. Both CVS Pharmacy® stores and MinuteClinic® walk-in medical clinics in the area have vaccines available to help protect patients against measles. Is Molina Healthcare Stock Underperforming the Dow?As Molina Healthcare has lagged behind the Dow over the past year, analysts remain cautious about the stock’s prospects. Jim Cramer on CVS: “This Stock Has Become the Best Performer in the Healthcare Sector”CVS Health Corporation (NYSE:CVS) is one of the stocks Jim Cramer recently commented on. Cramer praised the company’s CEO during the episode, as he commented: “This stock has become the best performer in the healthcare sector under CEO David Joyner and shot up another 2% today as management laid out some bullish long-term earnings targets.” […] |